Temporal Patterns of Allergen Sensitisation in the General Population: The LEAD Study
Clinical and Translational Allergy · 2026-06 · 16 (6)
DOI: 10.1002/clt2.70181 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Allergy, online erschienen am 12.06.2026. Verfasst von Charmaine J M Lim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Ludwig Boltzmann Institute for Lung Health, Vienna, Austria. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Allergic sensitisation is traditionally viewed as a stable trait despite studies suggesting that it may vary across life‐course. This study aims to provide longitudinal evidence of allergic sensitisation and its associated factors in the general population.
Methods
Aeroallergen sensitisation was assessed in the Austrian population‐based cohort using repeated skin prick testing (SPT) across 3 visits (mean visit interval, 4.25 ± 0.33 years). Longitudinal sensitisation patterns were characterised as stable nonsensitised, stable sensitised, new‐onset, resolution or fluctuating. We examined demographic, metabolic, behavioural, environmental and immunological factors across age strata (< 18, 18 ≤ 40, 40 ≤ and ≥ 60 years).
Results
Among 5046 individuals with follow‐up and valid SPT in all 3 visits, 54.4% remained stably nonsensitised and 30.6% stably sensitised, 5.6% experienced resolution, 4.8% new onset and 4.6% fluctuating sensitisation. New onset expectedly predominated in < 18 years, fluctuation in 18 ≤ 60 years and resolution in ≥ 60 years, indicating that sensitisation is modifiable and time‐varying. Stable sensitisation was strongly associated with parental allergy and blood eosinophils while cumulative smoking modestly reduced its likelihood. Fluctuation was linked to adiposity (in adults ≥ 40 years old) and environmental exposures. Aeroallergen‐specific analysis showed new‐onset sensitisation was driven by outdoor allergens (ragweed, tree pollens and pets) whereas fluctuation was driven by seasonal pollens.
Conclusion
Although predominantly stable, allergic sensitisation is dynamic and exhibits substantial temporal variation. Resolution and fluctuation occur across all ages and new sensitisation can emerge well into adulthood. These findings challenge the traditional view of fixed sensitisation and suggest it reflects a modifiable phenotype shaped by age and environmental and lifestyle exposures.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ludwig Boltzmann Institute for Lung Health, Vienna, Austria.
- Sigmund Freud Private University, Faculty of Medicine, Vienna, Austria.
- Department of Respiratory and Pulmonary Diseases, Clinic Hietzing, Vienna Healthcare Group, Vienna, Austria.
- Department of Respiratory and Pulmonary Diseases, Site Penzing of Clinic Ottakring, Vienna Healthcare Group, Vienna, Austria.
- NUTRIM, Institute for Nutrition and Translational Research in Metabolism, Maastricht, the Netherlands.
- Department of Respiratory Medicine, Maastricht University Medical Center, Maastricht, the Netherlands.
Zitieren
APA
Lim, C. J. M., Omar, A., Pötscher, S., Breyer, M. K., Franssen, F. M. E., Wouters, E. F. M., & Breyer-Kohansal, R. (2026). Temporal Patterns of Allergen Sensitisation in the General Population: The LEAD Study. Clinical and Translational Allergy, 16(6). https://doi.org/10.1002/clt2.70181
Vancouver
Lim CJM, Omar A, Pötscher S, Breyer MK, Franssen FME, Wouters EFM, et al. Temporal Patterns of Allergen Sensitisation in the General Population: The LEAD Study. Clinical and Translational Allergy. 2026;16(6). doi:10.1002/clt2.70181
BibTeX
@article{Lim2026,
author = {Lim, Charmaine J M and Omar, Abdelrahman and Pötscher, Severin and Breyer, Marie-Kathrin and Franssen, Frits M E and Wouters, Emiel F M and Breyer-Kohansal, Robab},
title = {Temporal Patterns of Allergen Sensitisation in the General Population: The LEAD Study},
journal = {Clinical and Translational Allergy},
year = {2026},
volume = {16},
number = {6},
doi = {10.1002/clt2.70181}
}
EUVIMED